Abstract |
An efficacy of high dosages of piracetam in the treatment of children with Kozhevnikov epilepsy syndrome ( epilepsia partialis continua) has been studied. The study included 6 patients, aged from 9 to 16 years, with diagnosis of Kozhevnikov epilepsy (KE) who received piracetam ( nootropil, UCB) in mean dose of 1g/kg/day (up to 35 g/day) intravenous in drops. The treatment course was 30 days. During therapy, there was decrease of myoclonus frequency by 75% in 3 patients and its full stopping in 3 patients. Focal clonic seizures were stopped in 2 cases, their frequency decreased in 4 cases. Secondary generalized seizures did not relapse in 2 cases and there was a decrease of seizures by 50% and over in 4 remained cases. The use of nootropil led to the improvement of neurological status in 5 out of 6 patients with KE. The intensity of hemiparesis was reduced in 3 patients treated with nootropil. The improvement of cognitive functioning was observed in 5 out of 6 patients. The duration of clinical improvement was 1-2 months after infusions cessation. The study revealed the efficacy of high dosages of nootropil in combination with basic antiepileptic drugs in the treatment of Kozhevnikov epilepsy.
|
Authors | K Iu Mukhin, S V Piliia, E Iu Volkova, V A Chadaev, M B Mironov, N E Kvaskova, A S Petrukhin |
Journal | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
(Zh Nevrol Psikhiatr Im S S Korsakova)
Vol. 107
Issue 3
Pg. 30-6
( 2007)
ISSN: 1997-7298 [Print] Russia (Federation) |
PMID | 18379510
(Publication Type: Comparative Study, English Abstract, Journal Article)
|
Chemical References |
- Nootropic Agents
- Piracetam
|
Topics |
- Adolescent
- Child
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Electroencephalography
- Epilepsia Partialis Continua
(drug therapy, physiopathology)
- Female
- Follow-Up Studies
- Humans
- Infusions, Intravenous
- Male
- Nootropic Agents
(administration & dosage)
- Piracetam
(administration & dosage)
- Treatment Outcome
|